This course will provide clinically-relevant updates on the emerging treatments, technologic advances and supportive care interventions for patients with primary and metastatic brain tumors.
Offered by Dana-Farber/Brigham and Women’s Cancer Center, Massachusetts General Hospital Cancer Center, and Harvard Medical School Department of Continuing Education
Credits: 7.5 AMA PRA Category 1 Credits
This course is designed to provide medical oncologists, neurologists, neurosurgeons, radiation oncologists, and other interested clinicians with clinically-relevant updates on the management of primary and metastatic brain tumors. Through lectures, case-based presentations and Q&A, participants will learn about emerging treatment strategies, technologic advances and supportive care interventions, as well as how to integrate these concepts in daily practice.
At the conclusion of this course, attendees will be able to: describe evolving treatment strategies and promising advances for newly diagnosed and recurrent primary and metastatic brain cancers; recognize technologic advances in neurosurgery, radiation therapy, neuroimaging and tumor analysis for brain tumors that impact care for brain tumors; and review supportive care and quality of life interventions for brain tumor patients.
This course has been designed to enhance the following Accreditation Council for Graduate Medical Education competencies: Patient care, Medical knowledge, Practice-based learning and improvement.
This course will be held at Dana-Farber’s Yawkey Center for Cancer Care in the Yawkey Conference Center, located on the 3rd floor, 450 Brookline Avenue, Boston, MA. Complimentary parking is available in the Dana-Farber garage located on Jimmy Fund Way. For directions, visit www.dana-farber.org/directions.
For complete information. program details and registration, visit http://www.dfbwcc.org/classes/2013-05-04-Tumors.html